CareDx, Inc.

CDNA · Medical Laboratories · $2.8B
Powering up
CDNA
$53.83
▼ −0.83%
09/18 O 53.97 H 54.46 L 53.12 C 53.83 ▼ −0.83%
Vol 1.4M RS 98
RS rating98
Now vs pivot (%)+8.18%
Tightening (ATR ratio)1.54×
Volume dry-up1.33×
Up/down volume, net0.28
From 52-week high2%
climbing
Previous breakout stopped out ▼ −10.53% in Apr
Powering up
Moving averages
9-dayabout two weeks21-dayabout a month50-dayabout a quarter200-dayabout a year

All four are in order, fastest above slowest — every timeframe pointing the same way.

The read

The base has run 3.2 weeks and fell 10% from its ceiling at its deepest. The pivot is $49.76, and the stock closed 8.2% above that pivot. Its relative strength rating is 98.

Also on
Peers
Same theme
No themes — common and fine.
Catalyst roadmap
  1. Earningstentativein 46d
    Quarterly earnings
    Nov 3, 2026
Flagged by the market sweep
Red flag in a filingFiling · 2026-09-17
going concern

From a separate overnight market sweep, not from the screens on this site. What it flagged, not what it means.

In the news
Insiders

No Form 4 filings read for this company in the last six months. That can mean nobody filed, or that this name has not been on a screen long enough for us to have fetched them.

X-ray

A screening and market-analytics tool. Not investment advice. We are not a registered investment adviser. Historical figures are backtests and are hypothetical.

What that means, in full
CareDx, Inc. (CDNA) — The Tape